期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

氟尿嘧啶衍生物维持治疗对晚期胃癌无进展生存期的影响 被引量：5

氟尿嘧啶衍生物维持治疗对晚期胃癌无进展生存期的影响
原文传递
导出
摘要 胃癌是我国最常见的恶性肿瘤之一，其死亡率仅次于肺癌、肝癌。大量临床实践与实验证明，一线化学药物，如紫杉醇、多西紫杉醇、顺铂、卡铂、奥沙利铂、氟尿嘧啶、依立替康等联合化学治疗可以延长胃癌患者的生存期。目前，对于晚期胃癌姑息化疗常选用氟尿嘧啶类、紫杉类和铂类、
作者 林小燕 郑建伟 侯培锋 王新利 赖金火 陈强
机构地区 福建医科大学附属协和医院肿瘤内科
出处 《中国肿瘤临床与康复》 2011年第6期551-554,共4页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 胃肿瘤 希罗达 替吉奥 治疗 Stomach neoplasms Xeloda Tegafur Therapy
分类号 R735.2 [医药卫生—肿瘤] R730.53 [医药卫生—肿瘤]
  • 相关文献

参考文献10

  • 1Paz-Ares LG,Altug S,Vaury AT,et al.Treatment rationale andstudy design for a phaseⅢ,double-blind,placebo-controlledstudy of maintenance pemetrexed plus best supportive care versusbest supportive care immediately following induction treatmentwith pemetrexed plus cisplatin for advanced non-squamous non-small cell lung cancer[J].BMC Cancer,2010,10:85.
  • 2Fidias P,Dakhil S R,Lyss A P,et al.PhaseⅢstudy of immedi-ate versus delayed docetaxel after induction therapy with gemcit-abine plus carboplatin in advanced non-small-cell lung cancer:Updated report with survival[J].Proc Am Soc Clin Oncol,2007,25:18.
  • 3Brodowicz T,Krzakowski M,Zwitter M,et al.Cisplatin and gem-citabine first-line chemotherapy followed by maintenance gemcit-abine or best supportive care in advanced non-small cell lungcancer:a phaseⅢtrial[J].Lung Cancer,2006,52:155-163.
  • 4Cappuzzo F,Ciuleanu T,Stelmakh L,et al.Maintenance peme-trexed plus best supportive care versus placebo plus best support-ive care for non-small-cell lung cancer:a randomised,double-blind,phase 3 study[J].Lancet,2009,374:1432-1440.
  • 5Cappuzzo F,Ciuleanu T,Stelmakh L,et al.Erlotinib as mainte-nance treatment in advanced non-small-cell lung cancer:a multi-centre,randomised,placebo-controlled phase 3 study[J].Lan-cet Oncol,2010,11:521-529.
  • 6Therasse P,Arbuck SG,Eisenhauer EA,et al.New guidelinesto evaluate the response to treatment in solid tumors,EuropeanOrganization for Research and Treatment of Cancer,NationalCancer Institute of the United States.National Cancer Institute ofCanada[J].J Natl Cancer Inst,2000,92:205-216.
  • 7Miwa M,Ura M,Nishida M,et al.Design of a novel oral fluoro-pyrimidine carbamate,capecitabine,which generates 5-fluoroura-cil selectively in tumours by enzymes concentrated in human liverand cancer tissue[J].Eur J Cancer,1998,34:1274.
  • 8Hong YS,Song SY,Lee SI,et al.A phaseⅡtrial of capecit-abine in previously untreated patients with advanced and/or meta-static gastric cancer[J].Ann Oncol,2004,15:1344-1347.
  • 9刘莉,郑盈,张智勇,丁昌利,陆震宇.替吉奥单药口服治疗老年晚期胃癌的临床观察[J].实用癌症杂志,2011,26(3):294-296. 被引量：65
  • 10Koizumi W,Narahara H,Hara T,et al.S-1 plus cisplatin versusS-1 alone for first-line treatment of advanced gastric cancer(SPI-RITS trial):a phaseⅢtrial[J].Lancet Oncol,2008,9:215-221.

二级参考文献8

  • 1Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74.
  • 2Miller A B,Hoogstraten B,Staquet M,et al.Reporting results of cancer treatment[J].Cancer,1981,47(1):207.
  • 3Alberts SR,Cervantes A,VANDE Velde CJ,et al.Gastric cancer:epidemiology,pathology and treatment[J].Ann Oncol,2003,14(suppl 2):S31.
  • 4Sato A,Ito T,Tomita T.Chemotherapy of gastric cancer-a review of clinical trials in Japan 2002[J].Gan To Kaggku Ryobo,2002,29(9):1522.
  • 5Koizumi W.S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer.(SPIRITS trial):a phase Ⅲ trial[J].Lancet Oncol,2008,9(3):215.
  • 6Boku N.Chemotherapy for metastatic disease:review from JCOG trials[J].International Journal of Clinical Oncology,2008,13(3):196.
  • 7白坂哲彦 佃守犬山 夫他新规.经口抗癌剂TS-1(S-1).癌症化学疗法,2001,:855-864.
  • 8周际昌.实用肿瘤内科学[M].第2版.北京:人民卫生出版社,2005.386-388.

共引文献64

同被引文献44

引证文献5

二级引证文献22

中国肿瘤临床与康复
2011年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部